Search results
Results from the Tech24 Deals Content Network
With the stock price under pressure, the shares offer an unusually high 4.8% dividend yield. Why Bristol Myers Squibb stock looks like a good investment now.
Bristol Myers Squibb: A high-yield dividend stock with an attractive valuation. Bristol Myers Squibb, or BMS for short, is another well-established pharmaceutical company with a strong presence in ...
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [ 2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
Bristol-Myers Squibb (BMY) closed at $60.50 in the latest trading session, marking a -1.59% move from the prior day.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Bristol-Myers Squibb (BMY) have what it takes? Let's find out.
In April 2007, The Wall Street Journal reported that "Bristol-Myers Squibb Co. and ImClone Systems Inc. said their cancer drug, Erbitux, failed to significantly prolong the lives of people with pancreatic cancer in a new study, marking yet another setback in the drug industry's efforts to find a better treatment for this deadly disease."
Let's see if Bristol-Myers Squibb Company (BMY) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Source: Shutterstock. Bristol-Myers Squibb (NYSE:BMY) reported earnings per share of $1.18 for the second quarter of 2019.This is better than the company’s earnings per share of $1.01 from the ...